-+ 0.00%
-+ 0.00%
-+ 0.00%

Simcere Wins China Clinical Trial Approval for SIM0712

PUBT·11/16/2026 10:15:05
Simcere Wins China Clinical Trial Approval for SIM0712
  • Simcere Pharmaceutical received China’s National Medical Products Administration clearance to test SIM0712, an oral STAT6 degrader, for atopic dermatitis.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simcere Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261116-12414370), on November 16, 2026, and is solely responsible for the information contained therein.